Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

UOP HC-DM-1.3Q UNIONFINING CATALYST

NFPA

PRODUCT USE

Catalyst.

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

Danger of cumulative effects.
May cause CANCER.
May cause SENSITIZATION by skin contact.
Harmful: danger of serious damage to health by prolonged exposure through
inhalation and if swallowed.
Irritating to eyes and respiratory system.

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Accidental ingestion of the material may be damaging to the health of the individual.  Molybdenum, an essential trace element, can in large doses hamper growth and cause loss of appetite, listlessness and diarrhea. Anemia also occurs, and other symptoms include graying of hair, shrinking of the testicles, reduced fertility and milk production, shortness of breath, incoordination and irritation of the mucous membranes. Symptoms of copper deficiency are also seen.  

EYE

  This material can cause eye irritation and damage in some persons.  

SKIN

  The material is not thought to produce adverse health effects or skin irritation following contact (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting.  Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably protected.  

INHALED

  The material can cause respiratory irritation in some persons. The body's response to such irritation can cause further lung damage.  The material is not thought to produce adverse health effects following inhalation (as classified using animal models). Nevertheless, adverse effects have been produced following exposure of animals by at least one other route and good hygiene practice requires that exposure be kept to a minimum and that suitable control measures be used in an occupational setting.  Persons with impaired respiratory function, airway diseases and conditions such as emphysema or chronic bronchitis, may incur further disability if excessive concentrations of particulate are inhaled.  Molybdenum, an essential trace element, can in large doses hamper growth and cause loss of appetite, listlessness and diarrhea. Anemia also occurs, and other symptoms include graying of hair, shrinking of the testicles, reduced fertility and milk production, shortness of breath, incoordination and irritation of the mucous membranes. Symptoms of copper deficiency are also seen.  

CHRONIC HEALTH EFFECTS

  Harmful: danger of serious damage to health by prolonged exposure through inhalation and if swallowed.  This material can cause serious damage if one is exposed to it for long periods. It can be assumed that it contains a substance which can produce severe defects. This has been demonstrated via both short- and long-term experimentation.  There is some evidence that inhaling this product is more likely to cause a sensitization reaction in some persons compared to the general population.  High levels of molybdenum can cause joint problems in the hands and feet with pain and lameness. Molybdenum compounds can also cause liver changes with elevated levels of enzymes and cause over-activity of the thyroid gland. A generalized feeling of unwellness can occur, with tiredness, weakness, diarrhea, loss of appetite and weight. Molybdenum has been associated with cancers of the airways, but on the other hand, a low intake of molybdenum may cause an increased risk of developing esophageal cancer.  Limited evidence suggests that repeated or long-term occupational exposure may produce cumulative health effects involving organs or biochemical systems.  Repeated exposures, in an occupational setting, to high levels of fine- divided dusts may produce a condition known as pneumoconiosis which is the lodgement of any inhaled dusts in the lung irrespective of the effect. This is particularly true when a significant number of particles less than 0.5 microns (1/50,000 inch), are present. Lung shadows are seen in the X-ray. Symptoms of pneumoconiosis may include a progressive dry cough, shortness of breath on exertion, increased chest expansion, weakness and weight loss. As the disease progresses the cough produces a stringy mucous, vital capacity decreases further and shortness of breath becomes more severe. Pneumoconiosis is the accumulation of dusts in the lungs and the tissue reaction in its presence. It is further classified as being of noncollagenous or collagenous types. Noncollagenous pneumoconiosis, the benign form, is identified by minimal stromal reaction, consists mainly of reticulin fibres, an intact alveolar architecture and is potentially reversible.